Activation of the Alternative Complement Pathway by Pneumococcal Cell Wall Teichoic Acid (original) (raw)
The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway
Jerry Winkelstein
Journal of Immunology, 1981
View PDFchevron_right
Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall
Jerry Winkelstein
Journal of Immunology, 1980
View PDFchevron_right
Brown, E.J., Joiner, K.A., Gaither, T.A., Hammer, C.H. & Frank, M.M. The interaction of C3b bound to pneumococci with factor H (1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. J. Immunol. 131, 409−415
Keith Joiner
The Journal of Immunology
View PDFchevron_right
Activation of the Alternative Pathway by Pneumococcal Cell Wall Teichoic Acid
Jerry Winkelstein
Journal of Immunology, 1978
View PDFchevron_right
Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2
Ger Rijkers
Infection and Immunity, 1991
View PDFchevron_right
Neeleman C, Geelen SP, Aerts PC, Daha MR, Mollnes TE, Roord JJ et al.Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun 67:4517-4524
Mohamed Daha
Infection and Immunity
View PDFchevron_right
Analysis of Complement C3 Deposition and Degradation on Klebsiella pneumoniae
Juan Tomas
1996
View PDFchevron_right
Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine
anh the
The Journal of Immunology, 2012
View PDFchevron_right
Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae
Anh The
1999
View PDFchevron_right
Activation of the alternative complement pathway by blood culture isolates of Bacteroides fragilis
Keith Joiner
Infection and Immunity
View PDFchevron_right
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
Jutta Loeffler
Cell, 2006
View PDFchevron_right
Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules
Keith Joiner
Infection and Immunity
View PDFchevron_right
Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity
Stephen Tomlinson
Biochemistry, 1990
View PDFchevron_right
In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways
Sherie L. Morrison
Molecular Immunology, 2011
View PDFchevron_right
Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from salmonella minnesota S218 without causing bacterial death
Keith Joiner
Journal of Experimental Medicine, 1982
View PDFchevron_right
Localization of complement component 3 on Streptococcus pneumoniae: Anti-capsular antibody causes complement deposition on the pneumococcal capsule
Keith Joiner
Infection and Immunity
View PDFchevron_right
Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates
Ger Rijkers
Medical Microbiology and Immunology, 1992
View PDFchevron_right
Interaction of Pneumococcal Histidine Triad Proteins with Human Complement
Jan Poolman
Infection and Immunity, 2010
View PDFchevron_right
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H
George Posthuma, Piet Aerts
Infection and immunity, 1999
View PDFchevron_right
Pneumococcal wall teichoic acid is required for the pathogenesis of Streptococcus pneumoniae in murine models
Jianing Wang
Journal of Microbiology, 2015
View PDFchevron_right
Characterization of cell wall polymers secreted into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis
R. Hakenbeck
Antimicrobial agents and chemotherapy, 1978
View PDFchevron_right
Mechanism of bacterial resistance to complement-mediated killing
Keith Joiner
Molecular Immunology, 1982
View PDFchevron_right
The Contribution of PspC to Pneumococcal Virulence Varies between Strains and Is Accomplished by Both Complement Evasion and Complement-Independent Mechanisms
Gavin Paterson
Infection and Immunity, 2006
View PDFchevron_right
The Pneumococcal Surface Proteins PspA and PspC Sequester Host C4-Binding Protein To Inactivate Complement C4b on the Bacterial Surface
Sven Hammerschmidt
Infection and Immunity, 2018
View PDFchevron_right
Immunogenetic analysis of the immune response to pneumococcal polysaccharide
Harry White
European Journal of Immunology, 2000
View PDFchevron_right
Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice
Ger Rijkers
The Journal of Immunology, 2003
View PDFchevron_right
Interaction between complement subcomponent C1q and bacterial lipopolysaccharides
Serge Chesne
Biochemical Journal, 1989
View PDFchevron_right
The Critical Role of Complement in Experimental Pneumococcal Sepsis
Stephen Hosea
Journal of Infectious Diseases, 1980
View PDFchevron_right
An alternative role of C1q in bacterial infections: Facilitating Streptococcus pneumoniae adherence and invasion of host cells
Kristian Riesbeck
Immunobiology, 2012
View PDFchevron_right